MOTS-c: A Mitochondrial Signal With Predominantly Preclinical Evidence

Reviewed for accuracy by the Gorilla Research Insights research team · 2026-07-04

MITOCHONDRIAL-DERIVED PEPTIDES MOTS-c: A Mitochondrial Signal With Predominantly Preclinical Evidence MOTS-c is a short peptide encoded within mitochondrial 12S rRNA. It has opened a serious line of research into communication between mitochondrial and nuclear systems, but it is not an established human performance or longevity intervention.

Discovery and mechanism

The original report identified MOTS-c as a mitochondrial-encoded peptide and described metabolic effects in cells and mice, including AMPK-linked responses ^[1]. Later work found that metabolic stress can drive MOTS-c into the nucleus, where it influences stress-response gene expression ^[2]. These are mechanistic and preclinical findings.

Human evidence

Human studies have measured endogenous MOTS-c rather than establishing effects of an administered product. Exercise studies reported changes in tissue or circulating mitochondrial-derived peptides, alongside extensive mouse experiments ^[3][4]. Such associations do not show that externally supplied MOTS-c reproduces exercise or improves a clinical outcome.

What remains open

Researchers still need validated assays, pharmacokinetics, target engagement, dose-ranging, and controlled human outcome trials. Age, exercise state, sampling time, and assay method may all affect endogenous measurements. Claims about fat loss, endurance, glucose control, recovery, or healthy aging therefore remain hypotheses.

Primary sources

• ^[1] Lee et al. MOTS-c discovery and metabolic regulation . • ^[2] Kim et al. Stress-induced nuclear translocation of MOTS-c . • ^[3] Reynolds et al. MOTS-c, exercise, and physical decline in mice and human samples . • ^[4] D'Souza et al. Acute exercise and circulating mitochondrial-derived peptides . Educational material only. It does not provide dosing or use advice.